These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27976818)

  • 1. Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.
    Zhang S; Wang Z; Hu Z; Li C; Tang C; Carlson KE; Luo J; Dong C; Katzenellenbogen JA; Huang J; Zhou HB
    ChemMedChem; 2017 Feb; 12(3):235-249. PubMed ID: 27976818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ER subtype selectivity of m-carborane-containing phenols: C-alkyl groups on the m-carborane cage enhance ERα selectivity.
    Ohta K; Ogawa T; Kato K; Oda A; Endo Y
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2290-2293. PubMed ID: 31248773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiophene-core estrogen receptor ligands having superagonist activity.
    Min J; Wang P; Srinivasan S; Nwachukwu JC; Guo P; Huang M; Carlson KE; Katzenellenbogen JA; Nettles KW; Zhou HB
    J Med Chem; 2013 Apr; 56(8):3346-66. PubMed ID: 23586645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced estrogen receptor beta (ERβ) selectivity of fluorinated carborane-containing ER modulators.
    Ohta K; Ogawa T; Kaise A; Endo Y
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6555-8. PubMed ID: 24268550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chlorine or fluorine substitution on the estrogenic properties of 1-alkyl-2,3,5-tris(4-hydroxyphenyl)-1H-pyrroles.
    Schäfer A; Wellner A; Strauss M; Schäfer A; Wolber G; Gust R
    J Med Chem; 2012 Nov; 55(22):9607-18. PubMed ID: 23043242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.
    Meyers MJ; Sun J; Carlson KE; Marriner GA; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2001 Nov; 44(24):4230-51. PubMed ID: 11708925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches.
    Zhang L; Sedykh A; Tripathi A; Zhu H; Afantitis A; Mouchlis VD; Melagraki G; Rusyn I; Tropsha A
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):67-76. PubMed ID: 23707773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure.
    Kojima T; Ogawa T; Kitao S; Sato M; Oda A; Ohta K; Endo Y
    Bioorg Med Chem; 2015 Nov; 23(21):6900-11. PubMed ID: 26462053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.
    Clegg NJ; Paruthiyil S; Leitman DC; Scanlan TS
    J Med Chem; 2005 Sep; 48(19):5989-6003. PubMed ID: 16162002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diaryl-substituted salicyl- and anthranyl-ketoximes as potential estrogen receptor ligands.
    Minutolo F; Antonello M; Bertini S; Placanica G; Rapposelli S; Carlson KE; Katzenellenbogen JA; Macchia M
    Farmaco; 2004 Aug; 59(8):601-7. PubMed ID: 15262529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO; Nadiminty N; Wu XX; Lou W; Dong Y; Ip C; Onate SA; Gao AC
    Cancer Res; 2005 Apr; 65(8):3487-92. PubMed ID: 15833885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the β-lactam type molecular scaffold for selective estrogen receptor α modulator action: synthesis and cytotoxic effects in MCF-7 breast cancer cells.
    Carr M; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    J Enzyme Inhib Med Chem; 2016; 31(sup3):117-130. PubMed ID: 27476825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ligands balance estrogen receptor β and α agonism for safe and effective suppression of the vasomotor response in the ovariectomized female rat model of menopause.
    McGregor C; Sau A; Ruddy SC; Leung D; Webb M; Durst T; Wright JS; Lagace D; Pratt MA
    Endocrinology; 2014 Jul; 155(7):2480-91. PubMed ID: 24823389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK; Leung TH; Chan DW; Wei N; Lau GT; Liu SS; Siu MK; Ngan HY
    J Endocrinol; 2014 May; 221(2):325-36. PubMed ID: 24819599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity.
    Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL
    J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta.
    Minutolo F; Bertini S; Granchi C; Marchitiello T; Prota G; Rapposelli S; Tuccinardi T; Martinelli A; Gunther JR; Carlson KE; Katzenellenbogen JA; Macchia M
    J Med Chem; 2009 Feb; 52(3):858-67. PubMed ID: 19128016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.